Key result
Monoclonal antibody 8A2 enhances vascular smooth muscle cell adhesion and inhibits PDGF-BB-induced migration.
Answers are grounded in this paper and cite their sources.
Avidity modulation and function of beta1-integrin receptors in cultured human vascular smooth muscle cells (SMCs) were investigated using monoclonal antibody (mAb) 8A2, which binds to the beta1 subunit of integrin heterodimers and induces a high avidity state. The adhesion of SMCs to extracellular matrix proteins, but not to poly-L-lysine, was enhanced by pretreatment with mAb 8A2. A qualitative alteration of beta1 integrin was assessed with mAb 15/7, which binds to an activation-dependent epitope on the beta1 subunit. Binding of mAb 15/7 was enhanced by mAb 8A2 in a dose-dependent manner. Arg-Gly-Asp peptide and soluble fibronectin also enhanced expression of the 15/7 epitope, suggesting that the 15/7 epitope is closely related to the ligand-occupied state of beta1 integrin. Platelet-derived growth factor (PDGF)-AA and -BB increased SMC adhesion to type I collagen but did not augment mAb 15/7 binding, suggesting that PDGFs increase binding avidity by a postreceptor mechanism. In addition, mAb 8A2 inhibited PDGF-BB-induced SMC migration through Matrigel-coated filters. These results suggest that avidity modulation of beta1 integrin may play an important role in the function of SMCs.
No takes yet. Share an insight, caveat, or question.
Seki et al. (1996) studied Vascular smooth muscle cell beta1-integrin regulation. Monoclonal antibody (mAb) 8A2, RGD peptide, soluble fibronectin, and PDGF-AA/BB was evaluated on Adhesion of SMCs to extracellular matrix proteins, mAb 15/7 epitope binding, and SMC migration. Monoclonal antibody 8A2 enhanced cultured human vascular smooth muscle cell adhesion to extracellular matrix proteins, dose-dependently increased mAb 15/7 binding, and inhibited PDGF-BB-induced migration.
Synapse has enriched 10 related papers. Consider them for comparative context: